Junichi Hanatani

7PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatmentsMedical infection agents (incl. prions)Medical biochemistry - inorganic elements and compoundsMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 16, 2026
Clinical Outcomes of Endoscopic Treatment for Asymptomatic and Symptomatic Common Bile Duct Stones: Incidence and Risk Factors for Post-ERCP Pancreatitis.

|Aug 13, 2026
Correction: Nishimura et al. Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut-Liver Axis and Epiregulin-IL-8-Associated Angiogenesis. Int. J. Mol. Sci. 2025, 26, 6710.

|Jul 28, 2026
Bovine Milk-Derived Extracellular Vesicles Ameliorate Steatohepatitis by Restoring Gut Barrier in CDA-HFD-Fed Mice.

|Feb 27, 2026
Multi-Hole Self-Expandable Metallic Stent for Malignant Distal Biliary Obstruction: A Literature Review.

Koh Kitagawa, Shohei Asada, Jun-Ichi Hanatani

|Dec 30, 2025
Diabetes as a Risk Factor for Sarcopenia in Patients with MASH-Related Cirrhosis.

Shinya Sato, Hiroaki Takaya, Tadashi Namisaki

|Oct 16, 2025
Creatinine-to-Cystatin C Ratio Combined with FIB-4 and ELF for Noninvasive Fibrosis Assessment in MASLD.

Masafumi Oyama, Tadashi Namisaki, Akihiko Shibamoto

Pageof 2

Frequent Collaborators

7 joint publications

Koh Kitagawa

6 joint publications

Norihisa Nishimura

6 joint publications

Shinya Sato

6 joint publications

Tadashi Namisaki